Clinical Trials Browser

Phase 4 × Interventional × Tamoxifen × Clear all

NCT01127295 2026-04-14

PHACS

Phase 4 Completed

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Phase 4 Completed

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Phase 4 Completed

Breast Neoplasms

NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

Breast Neoplasms

NCT03355157 2024-10-01

PADMA

Phase 4 Completed

Breast Neoplasms, Patient Acceptance of Health Care

NCT05525481 2023-11-01

PREDICTAM

Phase 4 Unknown

ER+ Breast Cancer

NCT03948568 2022-09-30

REaCT-RETT

Phase 4 Completed

Breast Neoplasms

NCT02344940 2019-09-24

TTOS

Phase 4 Completed

Breast Neoplasms

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

NCT02467686 2017-03-20

Cimicifuga

Phase 4 Unknown

Sexuality

NCT00999921 2015-05-18

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Phase 4 Completed

256 enrolled 8 charts

Cystic Fibrosis, Fibrocystic Breast Disease, Fibroadenoma, Mastodynia

NCT00537771 2013-01-25

HEART

Phase 4 Completed

384 enrolled 9 charts

Breast Neoplasms